2.1
Foslevodopa–foscarbidopa (Produodopa, AbbVie) is indicated for the 'treatment of advanced levodopa-responsive Parkinson's disease with severe motor fluctuations and hyperkinesia or dyskinesia when available combinations of Parkinson medicinal products have not given satisfactory results'.